Zydus Lifesciences to Acquire 85.6% of Amplitude Surgical, block acquisition expected by Q3 2025 Read more
Biocon Biologics receives positive CHMP opinions for denosumab biosimilars Vevzuo and Denosumab BBL Read more
Oxford Nanopore and BRIC Institutes sign Letters of Intent to establish two Centres of Excellence in genomics in India Read more